Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.

Source:http://linkedlifedata.com/resource/pubmed/id/10800167

Download in:

View as

General Info

PMID
10800167